SCHEMBL18868366

SCHEMBL18868366

c1ccc(-c2nc(-n3c4ccccc4c4cc5c6c7c(ccc6n(-c6ccccc6)c5cc43)oc3ccccc37)nc3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.38
HPGD P15428 4/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 4/20 0.38
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ATM Q13315 2/20 0.35
MAPK1 P28482 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADORA2A P29274 2/20 0.32
KMT2A Q03164 3/20 0.31
NUDT1 P36639 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HTT P42858 2/20 0.31
NPY1R P25929 1/20 0.31
HIF1A Q16665 1/20 0.31
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18868367 1.00 L3MBTL1 (0.38) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL22011422 0.97 L3MBTL1 (0.36) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL24172599 0.94 L3MBTL1 (0.37) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL16919332 0.91 L3MBTL1 (0.42) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL18620251 0.89 ALDH1A1 (0.39) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL18868180 0.89 ALDH1A1 (0.37) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL17299999 0.89 ALDH1A1 (0.37) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL20821799 0.89 L3MBTL1 (0.34) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL18868250 0.89 ALDH1A1 (0.38) L3MBTL1HPGDLMNAALDH1A1KDM4E
SCHEMBL18868257 0.89 ALDH1A1 (0.38) L3MBTL1HPGDLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10319918-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD (KR) 2019-06-11 US disclosed
US-20170352814-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-12-07 US disclosed
US-20170352814-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-12-07 US disclosed
US-9768394-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-09-19 US disclosed
US-9768394-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-09-19 US disclosed
US-20170141326-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-05-18 US disclosed
US-20170141326-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10319918-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same OR10J3, VDAC1, ICOSLG L3MBTL1 315/4885HPGD 3361/4885LMNA 2920/4885
US-20170352814-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, VDAC1, ICOSLG L3MBTL1 315/4885HPGD 3361/4885LMNA 2920/4885
US-20170141326-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, VDAC1, ICOSLG L3MBTL1 315/4885HPGD 3361/4885LMNA 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.